Micropapillary: A component more likely to harbour heterogeneous EGFR mutations in lung adenocarcinomas

Documenti analoghi

• Heterogeneous components of lung adenocarcinomas confer distinct EGFR mutation and PD-L1 expression
  di: Cai, Yiran, et al.
  Pubblicazione: (2020)
• Expression level of CRKL and AXL combined with exon 19 deletion in EGFR and ALK status confer differential prognosis of lung adenocarcinoma subtypes
  di: Cai, Yi-Ran, et al.
  Pubblicazione: (2016)
• Association between the histological subtype of lung adenocarcinoma, EGFR/KRAS mutation status and the ALK rearrangement according to the novel IASLC/ATS/ERS classification
  di: DONG, YU-JIE, et al.
  Pubblicazione: (2016)
• EGFR Mutation Heterogeneity and the Mixed Response to EGFR Tyrosine Kinase Inhibitors of Lung Adenocarcinomas
  di: Chen, Zhi-Yong, et al.
  Pubblicazione: (2012)
• Genetic alterations in lung adenocarcinoma with a micropapillary component
  di: FURUKAWA, MASASHI, et al.
  Pubblicazione: (2016)